- United States
- /
- Medical Equipment
- /
- NasdaqGS:LIVN
LivaNova PLC's (NASDAQ:LIVN) CEO Might Not Expect Shareholders To Be So Generous This Year
The results at LivaNova PLC (NASDAQ:LIVN) have been quite disappointing recently and CEO Damien McDonald bears some responsibility for this. At the upcoming AGM on 09 June 2021, shareholders can hear from the board including their plans for turning around performance. They will also get a chance to influence managerial decision-making through voting on resolutions such as executive remuneration, which may impact firm value in the future. We present the case why we think CEO compensation is out of sync with company performance.
Check out our latest analysis for LivaNova
Comparing LivaNova PLC's CEO Compensation With the industry
Our data indicates that LivaNova PLC has a market capitalization of US$3.9b, and total annual CEO compensation was reported as US$6.9m for the year to December 2020. That's a slight decrease of 3.2% on the prior year. We think total compensation is more important but our data shows that the CEO salary is lower, at US$974k.
In comparison with other companies in the industry with market capitalizations ranging from US$2.0b to US$6.4b, the reported median CEO total compensation was US$5.5m. This suggests that LivaNova remunerates its CEO largely in line with the industry average. What's more, Damien McDonald holds US$6.2m worth of shares in the company in their own name, indicating that they have a lot of skin in the game.
Component | 2020 | 2019 | Proportion (2020) |
Salary | US$974k | US$933k | 14% |
Other | US$5.9m | US$6.2m | 86% |
Total Compensation | US$6.9m | US$7.1m | 100% |
On an industry level, around 22% of total compensation represents salary and 78% is other remuneration. It's interesting to note that LivaNova allocates a smaller portion of compensation to salary in comparison to the broader industry. If total compensation is slanted towards non-salary benefits, it indicates that CEO pay is linked to company performance.
LivaNova PLC's Growth
Over the last three years, LivaNova PLC has shrunk its earnings per share by 63% per year. In the last year, its revenue is down 13%.
The decline in EPS is a bit concerning. And the fact that revenue is down year on year arguably paints an ugly picture. It's hard to argue the company is firing on all cylinders, so shareholders might be averse to high CEO remuneration. Historical performance can sometimes be a good indicator on what's coming up next but if you want to peer into the company's future you might be interested in this free visualization of analyst forecasts.
Has LivaNova PLC Been A Good Investment?
With a three year total loss of 17% for the shareholders, LivaNova PLC would certainly have some dissatisfied shareholders. So shareholders would probably want the company to be less generous with CEO compensation.
To Conclude...
Not only have shareholders not seen a favorable return on their investment, but the business hasn't performed well either. Few shareholders would be willing to award the CEO with a pay raise. At the upcoming AGM, they can question the management's plans and strategies to turn performance around and reassess their investment thesis in regards to the company.
CEO compensation can have a massive impact on performance, but it's just one element. We've identified 1 warning sign for LivaNova that investors should be aware of in a dynamic business environment.
Of course, you might find a fantastic investment by looking at a different set of stocks. So take a peek at this free list of interesting companies.
If you’re looking to trade LivaNova, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers. Their clients from over 200 countries and territories trade stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
About NasdaqGS:LIVN
LivaNova
A medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide.
Undervalued with excellent balance sheet.
Similar Companies
Market Insights
Community Narratives

